Dr. Mellick runs an Australian Research Council and National Medical Research Council funded lab, and he has authored many research publications focused on the understanding and treatment of cancer malignancy. Prior to his current appointment he has served as foundation Chair Pharmacology, Deakin University; foundation Griffith Medical Research College Fellow, and Research Fellow, Cold Spring Harbor Laboratories; where he developed methods in retro-viral delivery of inhibitory RNAs and published seminal papers on endothelial progenitors.